Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9600 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 27, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

Another week comes to a close, and it’s time to review the biggest stories of the week. Check out the …
News
takeda_deerfield_hq

Takeda’s Entyvio outperforms AbbVie’s Humira in moderate-to-severe ulcerative colitis

September 27, 2019 Medical Communications, Research and Development AbbVie, Entyvio, Humira, Takeda, pharma, ulcerative colitis

Takeda has released strong new data for Entyvio (vedolizumab), showing that the gut-selective biologic outperformed AbbVie’s blockbuster anti-tumour necrosis factor-alpha …
News
research

Male infertility linked to prostate cancer risk

September 26, 2019 Research and Development

Research published in the British Medical Journal has found a link that men who have fertility treatment have a higher …
News
Uk flag

UK announces research plan on evolving global health threats

September 26, 2019 Research and Development

The UK’s Chief Medical Officer, Professor Dame Sally Davies has announced funding for projects to help combat antimicrobial resistance (AMR) …
News

Springworks’ nirogacestat receives EC orphan status

September 26, 2019 Research and Development

Springworks, a clinical-stage biopharmaceutical company focusing on severe rare disease and cancer has been granted orphan status by the European …
News
610px-jeremy_corbyn_2016_labour_party_conference_10

Corbyn announces plan to ‘put public health before private profit’

September 25, 2019 Research and Development

Jeremy Corbyn has announced a new plan to set up a state-run drugs manufacturer to sell cheap medications to the …
News
takeda_world

Takeda’s investigational therapy shows promise as cytomegalovirus treatment

September 25, 2019 Research and Development, Sales and Marketing Takeda, cytomegalovirus, maribavir, pharma

New Phase 2 data has been released on Takeda’s investigational antiviral therapy TAK-620 (maribavir) in patients with cytomegalovirus (CMV) infection …
News
novartis_side_building

Novartis blames former AveXis execs for Zolgensma data manipulation

September 25, 2019 Research and Development

Novartis has placed blame on former executives Brian and Allan Kaspar for the manipulation of data behind its $2.1 million …
News
opdivo_1_1

EMA’s CHMP recommends new dosing schedule for Opdivo in melanoma

September 25, 2019 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, CHMP, EMA, melanoma, opdivo, pharma

Bristol-Myers Squibb has revealed that its blockbuster immunotherapy drug Opdivo (nivolumab) has secured recommendation from the EMA’s Committee for Medicinal …
News
Ipsen Logo

Ipsen announces positive phase 3 results in limb spastic hemiparesis

September 24, 2019 Manufacturing and Production, Research and Development

Ipsen has announced results from its ENGAGE study for the combination of Dysport (abobotulinumtoxinA) alongside Guided Self-rehabilitation contracts (GSC) which …
News
Takeda HQ

Evotec and Takeda enter into multi therapeutic area collaboration

September 24, 2019 Manufacturing and Production, Research and Development

Evotec have announced a strategic, multi-year drug discovery collaboration with Takeda, with both companies aiming to establish at least five …
News

Bayer’s Vitravki becomes first EU-approved tumour-agnostic therapy

September 24, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Cancer, Vitravki, pharma

Bayer has announced that its tyrosine receptor kinase (TRK) inhibitor Vitrakvi (larotrectinib) has scored approval from the European Commission for …
News
images

Medicinal cannabis product Epidyolex approved in EU for childhood epilepsy

September 24, 2019 Manufacturing and Production, Research and Development

GW Pharmaceuticals, a world leader in the development of cannabinoid prescription drugs has announced it has received approval from the …
News

Destiny Pharma’s Joe Eagle to step down from Board

September 23, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs to address the global crisis …
Appointment

Living with acute myeloid leukaemia

September 23, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acute myeloid leukaemia, feature, patient experience, pharma

Steve Rothberg was blindsided by an AML diagnosis that progressed rapidly with little warning. Ten years later, he discusses his …
Feature
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026